Metabolites analysis of plantamajoside based on gut microbiota-drug interaction
Hui Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yan Wang(Wuhan University), Hang Yu(Humboldt-Universität zu Berlin), Meng-Meng Bu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jin‐Yue Lu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jia-Chun Hu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jie Fu(Southwest Petroleum University), Jian‐Dong Jiang(Ningbo University), Zhengwei Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Xinyu Yang(Gansu Academy of Agricultural Sciences)
Cited by 20
Related Papers
Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study
|The Lancet Infectious Diseases|2020|720
Single-cell RNA-seq analysis reveals the progression of human osteoarthritis
|Annals of the Rheumatic Diseases|2018|481
Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier
|Proceedings of the National Academy of Sciences|2009|444
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
|Cancer Cell|2005|368
Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota
|Signal Transduction and Targeted Therapy|2021|315